{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:11Z","timestamp":1787019551438,"version":"build-2736575974"},"reference-count":61,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Relapsed or refractory (R\/R) disease occurs in up to 40% of patients with diffuse large B-cell lymphoma (DLBCL) following first-line immunochemotherapy. However, the molecular mechanisms underlying drug persistence remain incompletely defined. In this study, we performed single-cell RNA and B-cell receptor sequencing on paired diagnostic and R\/R samples from 8 patients who were either treatment-refractory or relapsed after remission, and validated our findings in 3 independent patient cohorts. We found that drug-persistent cells exhibited a transcriptional profile indicative of a less-differentiated state and adopted a memory B-cell\u2013like program with enhanced stemlike properties, which correlated with unfavorable clinical outcomes across multiple DLBCL cohorts. Functionally, drug-persistent cells showed significantly increased in vitro clonogenicity and in vivo tumor-initiating capacity. Mechanistically, the WNT signaling regulator casein kinase 1\u025b (CSNK1E) was upregulated in these stemlike drug-persistent cells, in part through the activation of the A proliferation-inducing ligand (APRIL)\u2013TNFRSF13B axis. Notably, CSNK1E inhibition impaired the growth and tumor-initiating capacity of drug-persistent cells and potentiated the efficacy of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)\u2013based treatment, both in vitro and in vivo. Together, our study reveals the stemlike transcriptional and functional properties of drug-persistent cells, and identifies CSNK1E as a critical mediator and therapeutic vulnerability that may improve the efficacy of standard immunochemotherapy in DLBCL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031156","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:54:34Z","timestamp":1772218474000},"page":"2633-2647","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["CSNK1E sustains stemlike drug persistence in diffuse large B-cell lymphoma"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7963-0170","authenticated-orcid":false,"given":"Xiang","family":"Li","sequence":"first","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Liu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Shi","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Shan","family":"Du","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-919X","authenticated-orcid":false,"given":"Di","family":"Fu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Juan","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Dai","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Chen","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Mei","family":"Yi","sequence":"additional","affiliation":[{"name":"2Department of Pathology, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"He","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Cheng","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Peng","family":"Xu","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"3P\u00f4le de Recherches Sino-Fran\u00e7ais en Science du Vivant et G\u00e9nomique, Laboratory of Molecular Pathology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7719-3216","authenticated-orcid":false,"given":"Jiahao","family":"Chen","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-1616","authenticated-orcid":false,"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"3P\u00f4le de Recherches Sino-Fran\u00e7ais en Science du Vivant et G\u00e9nomique, Laboratory of Molecular Pathology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9","key":"2026052811221891700_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"2026052811221891700_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"16","key":"2026052811221891700_bib3","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","article-title":"Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study","volume":"130","author":"Crump","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2026052811221891700_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41408-023-00970-z","article-title":"Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands","volume":"14","author":"Pennings","year":"2024","journal-title":"Blood Cancer J"},{"issue":"1","key":"2026052811221891700_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/asheducation-2016.1.366","article-title":"Diffuse large B-cell lymphoma: R-CHOP failure-what to do?","volume":"2016","author":"Coiffier","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"15","key":"2026052811221891700_bib6","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S1470-2045(15)00005-4","article-title":"Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas","volume":"16","author":"Sarkozy","year":"2015","journal-title":"Lancet Oncol"},{"issue":"6769","key":"2026052811221891700_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"5","key":"2026052811221891700_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"15","key":"2026052811221891700_bib9","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"2026052811221891700_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-023-01358-y","article-title":"Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma","volume":"8","author":"Shen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"2026052811221891700_bib11","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41375-021-01285-3","article-title":"Treatment resistance in diffuse large B-cell lymphoma","volume":"35","author":"He","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"2026052811221891700_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"10","key":"2026052811221891700_bib13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","article-title":"Cancer drug-tolerant persister cells: from biological questions to clinical opportunities","volume":"24","author":"Russo","year":"2024","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2026052811221891700_bib14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2020.10.027","article-title":"Persistent cancer cells: the deadly survivors","volume":"183","author":"Shen","year":"2020","journal-title":"Cell"},{"issue":"2","key":"2026052811221891700_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41375-022-01769-w","article-title":"Sustained activation of non-canonical NF-kappaB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL","volume":"37","author":"Lim","year":"2023","journal-title":"Leukemia"},{"issue":"7","key":"2026052811221891700_bib16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/bloodadvances.2018029660","article-title":"MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma","volume":"3","author":"Due","year":"2019","journal-title":"Blood Adv"},{"issue":"7","key":"2026052811221891700_bib17","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.7150\/thno.41362","article-title":"PI3K\/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"2026052811221891700_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41375-022-01747-2","article-title":"Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed\/refractory B-cell lymphoma","volume":"37","author":"Li","year":"2023","journal-title":"Leukemia"},{"issue":"10","key":"2026052811221891700_bib19","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ccell.2023.09.004","article-title":"Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: the randomized GUIDANCE-01 trial","volume":"41","author":"Zhang","year":"2023","journal-title":"Cancer Cell"},{"key":"2026052811221891700_bib20","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"2026052811221891700_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"13","key":"2026052811221891700_bib22","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"2026052811221891700_bib23","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","article-title":"UCell: robust and scalable single-cell gene signature scoring","volume":"19","author":"Andreatta","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"2026052811221891700_bib24","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.19.585637","article-title":"Mapping single-cell developmental potential in health and disease with interpretable deep learning","author":"Kang","year":"21  2024","journal-title":"bioRxiv"},{"issue":"10","key":"2026052811221891700_bib25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat Methods"},{"issue":"1","key":"2026052811221891700_bib26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"2026052811221891700_bib27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1182\/blood-2017-05-786947","article-title":"Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia","volume":"131","author":"Janovska","year":"2018","journal-title":"Blood"},{"issue":"6476","key":"2026052811221891700_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.aax0249","article-title":"Single-cell transcriptional diversity is a hallmark of developmental potential","volume":"367","author":"Gulati","year":"2020","journal-title":"Science"},{"issue":"4","key":"2026052811221891700_bib29","doi-asserted-by":"crossref","first-page":"102030","DOI":"10.1016\/j.xcrm.2025.102030","article-title":"Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology","volume":"6","author":"Wang","year":"2025","journal-title":"Cell Rep Med"},{"issue":"1","key":"2026052811221891700_bib30","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-024-49495-4","article-title":"Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma","volume":"15","author":"Yan","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"2026052811221891700_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ncb3493","article-title":"Human haematopoietic stem cell lineage commitment is a continuous process","volume":"19","author":"Velten","year":"2017","journal-title":"Nat Cell Biol"},{"issue":"8","key":"2026052811221891700_bib32","doi-asserted-by":"crossref","first-page":"110445","DOI":"10.1016\/j.isci.2024.110445","article-title":"Decoding human bone marrow hematopoietic stem and progenitor cells from fetal to birth","volume":"27","author":"Xie","year":"2024","journal-title":"iScience"},{"issue":"20","key":"2026052811221891700_bib33","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.2020005857","article-title":"The dangers of deja vu: memory B cells as the cells of origin of ABC-DLBCLs","volume":"136","author":"Venturutti","year":"2020","journal-title":"Blood"},{"issue":"9","key":"2026052811221891700_bib34","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1073\/pnas.0511137103","article-title":"Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells","volume":"103","author":"Luckey","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"2026052811221891700_bib35","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"issue":"22","key":"2026052811221891700_bib36","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"7873","key":"2026052811221891700_bib37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","article-title":"Cycling cancer persister cells arise from lineages with distinct programs","volume":"596","author":"Oren","year":"2021","journal-title":"Nature"},{"issue":"595","key":"2026052811221891700_bib38","doi-asserted-by":"crossref","first-page":"eaas8779","DOI":"10.1126\/scisignal.aas8779","article-title":"Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance","volume":"12","author":"Goldman","year":"2019","journal-title":"Sci Signal"},{"key":"2026052811221891700_bib39","doi-asserted-by":"crossref","first-page":"174147","DOI":"10.1016\/j.ejphar.2021.174147","article-title":"The role of CD44 in cancer chemoresistance: a concise review","volume":"903","author":"Yaghobi","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"2026052811221891700_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1476-4598-13-231","article-title":"Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis","volume":"13","author":"Schittek","year":"2014","journal-title":"Mol Cancer"},{"issue":"20","key":"2026052811221891700_bib41","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.15252\/embj.201696253","article-title":"Casein kinase 1-epsilon or 1-delta required for Wnt-mediated intestinal stem cell maintenance","volume":"36","author":"Morgenstern","year":"2017","journal-title":"EMBO J"},{"issue":"7","key":"2026052811221891700_bib42","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41556-020-0532-x","article-title":"Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels","volume":"22","author":"Roider","year":"2020","journal-title":"Nat Cell Biol"},{"issue":"50","key":"2026052811221891700_bib43","doi-asserted-by":"crossref","first-page":"eadd6403","DOI":"10.1126\/sciadv.add6403","article-title":"PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia","volume":"8","author":"Li","year":"2022","journal-title":"Sci Adv"},{"issue":"5","key":"2026052811221891700_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ni1454","article-title":"Pax5: the guardian of B cell identity and function","volume":"8","author":"Cobaleda","year":"2007","journal-title":"Nat Immunol"},{"issue":"2","key":"2026052811221891700_bib45","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4049\/jimmunol.182.2.890","article-title":"Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells","volume":"182","author":"Good","year":"2009","journal-title":"J Immunol"},{"issue":"22","key":"2026052811221891700_bib46","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1182\/blood-2011-05-353961","article-title":"TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow","volume":"118","author":"Tsuji","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2026052811221891700_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cell.2020.05.049","article-title":"TBL1XR1 mutations drive extranodal lymphoma by inducing a pro-tumorigenic memory fate","volume":"182","author":"Venturutti","year":"2020","journal-title":"Cell"},{"issue":"1","key":"2026052811221891700_bib48","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/2159-8290.CD-22-0561","article-title":"An aged\/autoimmune B-cell program defines the early transformation of extranodal lymphomas","volume":"13","author":"Venturutti","year":"2023","journal-title":"Cancer Discov"},{"issue":"6","key":"2026052811221891700_bib49","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","article-title":"Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence","volume":"11","author":"Duy","year":"2021","journal-title":"Cancer Discov"},{"issue":"7686","key":"2026052811221891700_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature25167","article-title":"Senescence-associated reprogramming promotes cancer stemness","volume":"553","author":"Milanovic","year":"2018","journal-title":"Nature"},{"issue":"1","key":"2026052811221891700_bib51","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cell.2020.11.018","article-title":"Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy","volume":"184","author":"Rehman","year":"2021","journal-title":"Cell"},{"issue":"23","key":"2026052811221891700_bib52","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1158\/0008-5472.CAN-22-2350","article-title":"CK1\u03b4 and CK1\u03b5 signaling sustains mitochondrial metabolism and cell survival in multiple myeloma","volume":"83","author":"Burger","year":"2023","journal-title":"Cancer Res"},{"issue":"1","key":"2026052811221891700_bib53","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1038\/s41598-018-31864-x","article-title":"Casein kinase 1 epsilon regulates glioblastoma cell survival","volume":"8","author":"Varghese","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"2026052811221891700_bib54","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni842","article-title":"BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells","volume":"3","author":"Claudio","year":"2002","journal-title":"Nat Immunol"},{"issue":"7","key":"2026052811221891700_bib55","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/89790","article-title":"Activation and accumulation of B cells in TACI-deficient mice","volume":"2","author":"Yan","year":"2001","journal-title":"Nat Immunol"},{"issue":"2","key":"2026052811221891700_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1074-7613(03)00025-6","article-title":"Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor","volume":"18","author":"Seshasayee","year":"2003","journal-title":"Immunity"},{"issue":"38","key":"2026052811221891700_bib57","doi-asserted-by":"crossref","first-page":"15401","DOI":"10.1073\/pnas.1200386109","article-title":"Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival","volume":"109","author":"Ou","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026052811221891700_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/eji.200636914","article-title":"To switch or not to switch--the opposing roles of TACI in terminal B cell differentiation","volume":"37","author":"Salzer","year":"2007","journal-title":"Eur J Immunol"},{"issue":"2","key":"2026052811221891700_bib59","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2006-04-015958","article-title":"Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL","volume":"109","author":"Chiu","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2026052811221891700_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.coi.2007.04.008","article-title":"B cells and the BAFF\/APRIL axis: fast-forward on autoimmunity and signaling","volume":"19","author":"Mackay","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"2026052811221891700_bib61","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","article-title":"Stem cell fate in cancer growth, progression and therapy resistance","volume":"18","author":"Lytle","year":"2018","journal-title":"Nat Rev Cancer"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/22\/2633\/2522848\/blood_bld-2025-031156-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/22\/2633\/2522848\/blood_bld-2025-031156-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:22:29Z","timestamp":1779981749000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/22\/2633\/566877\/CSNK1E-sustains-stemlike-drug-persistence-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":61,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026,5,28]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031156","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,28]]},"published":{"date-parts":[[2026,5,28]]}}}